The Relationship Between Typical and Atypical B-Cell Chronic lymphocytic leukemia : A comparative genomic hybridization-based study

by O'Connor, S., Su'ut, L., Morgan, G.J., Jack, A.S
Published 2000

Fluorescent polymerase chain reaction of a panel of CA repeats on chromosome 6 in the indolent phase of follicular centre cell lymphoma.

by Randerson, J., Cawkwell, L., Jack, A., Lewis, F., Johnson, P., Evans, P., Barrans, S., Morgan, G. J.
Published 1996

Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K/mTOR inhibition in myeloma cells is essential for their effective clinical applica...

by Aronson, L I, Davenport, E L, Mirabella, F, Morgan, G J, Davies, F E
Published 2013

MMSET is the key molecular target in t(4;14) myeloma

by Mirabella, F, Wu, P, Wardell, C P, Kaiser, M F, Walker, B A, Johnson, D C, Morgan, G J
Published 2013

Trisomy 12 is seen within a specific subtype of B-cell chronic lymphoproliferative disease affecting the peripheral blood/bone marrow and co-segregates with elevated expression of...

by Su'ut, L., O'Connor, S., Richard,, S.J, Jones, R.A, Robert, B.E, Davies, F.E, Fegan, C.D, Jack, A.S, Morgan, G.J.
Published 1998

FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells

by Davies, F.E, Rawstron, A.C, Pratt, G., O'Connor, S., Su'ut, L., Blythe, D., Fenton, J., Claydon, D., Child, J.A, Jack, A.S, Morgan, G.J.
Published 1999

Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease bur...

by Giles, S.L., deSouza, N.M., Collins, D.J., Morgan, V.A., West, S., Davies, F.E., Morgan, G.J., Messiou, C.
Published 2015

Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients

by Walker, B A, Wardell, C P, Brioli, A, Boyle, E, Kaiser, M F, Begum, D B, Dahir, N B, Johnson, D C, Ross, F M, Davies, F E, Morgan, G J
Published 2014

Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

by Pawlyn, C, Fowkes, L, Otero, S, Jones, J R, Boyd, K D, Davies, F E, Morgan, G J, Collins, D J, Sharma, B, Riddell, A, Kaiser, M F, Messiou, C
Published 2016

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

by Dimopoulos, M A, Leleu, X, Palumbo, A, Moreau, P, Delforge, M, Cavo, M, Ludwig, H, Morgan, G J, Davies, F E, Sonneveld, P, Schey, S A, Zweegman, S, Hansson, M, Weisel, K, Mateos, M V, Facon, T, Miguel, J F S
Published 2014

Genetic factors influencing the risk of multiple myeloma bone disease

by Johnson, D C, Weinhold, N, Mitchell, J, Chen, B, Stephens, O W, Försti, A, Nickel, J, Kaiser, M, Gregory, W A, Cairns, D, Jackson, G H, Hoffmann, P, Noethen, M M, Hillengass, J, Bertsch, U, Barlogie, B, Davis, F E, Hemminki, K, Goldschmidt, H, Houlston, R S, Morgan, G J
Published 2016